Efficacy of Bilateral Continuous Paravertebral Block for Off Pump Coronary Artery Bypass Surgery

Venkataswamy, Adoni, Ramakrishna, Nagaraja, and Singh: Efficacy of Bilateral Continuous Paravertebral Block for Off Pump Coronary Artery Bypass Surgery

Authors

INTRODUCTION

Maintaining hemodynamic stability in the perioperative period is the key factor in the management of off pump coronary artery bypass surgery (OPCAB). Pain causes sympatho-adrenal stimulation leading to alteration in hemodynamic parameters resulting in imbalance between myocardial oxygen demand and supply, which can precipitate perioperative myocardial ischemia1-2 Pain also hinders respiratory efforts leading to pulmonary complications and hypoxemia in the post operative period.

Various regional techniques have been in use in conjunction with general anaesthesia to alleviate pain. Unilateral paravertebral block has been used in MIDCAB (Minimally Invasive Direct Coronary artery Bypass surgery)2 and robotic assisted coronary artery bypass surgery.3 Bilateral paravertebral block has been successfully used in abdominal vascular sugery,4 bilateral thoracotomy5 and also for obstetric analgesia.6

In this study we attempted to evaluate the feasibility and efficacy of bilateral continuous paravertebral block in conjunction with general anaesthesia for OPCAB.

MATERIALS AND METHODS

After obtaining institutional ethical committee approval and written informed consent, a prospective randomised clinical study was conducted at Sri Jayadeva Institute of Cardiovascular Sciences and Research.

60 patients of either sex scheduled for elective OPCAB were studied. Patients were randomised into Group A (n=30) who received PVB or Group B (n=30) who received Inj Fentanyl IV infusion. Inclusion criteria were, patients who have been diagnosed with coronary artery disease (single, double or triple disease) requiring isolated CABG with median sternotomy, able to give their informed written consent and > 21 years of age.

Patients with infection at the site of PVB, failed PVB, anomaly of vertebral column, Left Main Coronary artery lesions, EF <40%, associated valvular heart disease or pre-existing neurological, respiratory, renal or liver diseases were excluded from the study.

All patients were pre-medicated with Inj. Midazolam 0.01mg/kg I.V before surgery. On arrival of patient in the operation theatre, ECG, pulse oximetry was applied and arterial cannulation was performed under LA.

Bilateral PVB was performed in the patient placed in sitting position. The puncture site was 2.5 cm lateral to the spinous process of the T3 or T4 vertebrae. A one and half inch hypodermic needle was used for local infiltration of Inj Xylocaine 2% and also to identify the transverse spinous process. A 16G Touhy needle was passed between the transverse process of T3 and T4 or T4 and T5 and the paravertebral space was identified by loss of resistance technique with a saline filled syringe. An 18G catheter was passed through the needle and approximately 3 cm of the catheter was left in the space. The procedure was performed on either side of the spine. After securing the catheters patient was placed in supine position. A bolus dose of 0.25ml/kg of Inj Bupivacaine 0.25% was injected through both the catheters after negative aspiration for blood and CSF and followed by an infusion of Inj Bupivacaine 0.125% at the rate of 0.15ml/kg/hr in both the catheters.

Anaesthesia was induced in all patients with Inj. Fentanyl 5µg/kg IV, Inj. Midazolam 0.05mg/kg IV, Inj. Vecuronium 0.1mg/kg IV and Inj. Propofol 0.5-1mg/kg IV. Anaesthesia was maintained with Isoflurane in oxygen-air mixture and muscle relaxation with vecuronium 1 µg/kg/hr in both the groups. An infusion of Inj Fentanyl 1µg/kg/hr was started in Group B patients. Surgical team was same for all the cases. Monitoring included lead ECG with ST-T analysis, invasive arterial blood pressure monitoring, temperature, pulse oximetry, ETCO2, urine output, Activated Clotting Time and ABG analysis. Hemodynamic parameters recorded were heart rate, mean arterial pressure and central venous pressure.

After the surgery, patients were transferred to post-surgical ICU and extubated when deemed fit. Quality of analgesia was assessed by an anaesthesiologist who was not involved in the clinical care of the patient. Visual Analogue Scale (VAS) at 0hr, 4hr, 8hr, 12hr, 24 hr and 36 hr at rest and deep breathing were recorded. (0-3=mild pain, 4-7=moderate pain; >7 severe pain). Inj. Bupivacaine 0.125% at the rate of 0.15ml/kg/hr was continued post-operatively in Group A patients. Group B patients received analgesia in the form of Inj. Tramadol 1mg/kg IV TID. Patients with a VAS score of >4 or on patient demand, rescue analgesia as Inj. Diclofenac 75mg I.M was administered in both groups. The number of rescue analgesia required, total time to extubation, length of ICU stay and hospital stay were recorded. Any complications were also noted. The data was analysed using SPSS v 21 software. All the data were presented as Mean +/- S.D. Unpaired t-test was used to analyse the data of the mean value of the 2 groups. Chi-square test was used to analyse the categorical data. p value <0.05 is considered as statistically significant.

RESULTS

The demographic data in both groups were comparable (Table 1). The number of grafts and ejection fraction were also comparable in both the groups.

Table 1

Demographic Data which was comparable between 2 groups.

PVBCONTROLP VALUE
Age49.7352.80.12
Weight62.0767.070.343
Height162.4162.870.190
Gender22190.29
811
Ejection Fraction (%)54.25+/-7.02551.01+/-6.250.747
Preoperative Medications
  • ACEI

  • Beta Blockers,

  • Calcium Channel Blockers

  • ACEI +CCB

8
4
7
11
9
5
8
8
0.812
Number Of Grafts3.05+/-0.6042.8+/-0.520.170
Duration Of Surgery286+/-37.57265+/-32.430.415
Inotrope Score (24hrs)4.85+/-1.814.25+/-1.370.097

The intraoperative hemodynamic data recorded at various intervals was also comparable in both the groups.

The average fentanyl dose required in Group A was 403.33± 83.38 µg and in Group B was 600 ± 93.47 µg which was statistically significant with p value of 0.044.

The average extubation time in Group A was 266.67± 79.34 min and in Group B was 383.33 ± 74.03 min which was not statistically significant. (Graph 1).

Graph 1

Average Extubation time in Group A (PVB) was 266.67+/- 79.34 min Vs Group B (Control) was 383.33+/- 74.03 min.

https://s3-us-west-2.amazonaws.com/jourdata/jcdr/JCardVascDisRes-9-2-59_g000.jpg

There was a statistically significant increase in the heart rate post operatively in Group B, while the Mean Arterial Pressure was comparable between the two groups. (Graph 2).

Graph 2

Changes in Heart Rate and MAP was comparable in both the groups.

https://s3-us-west-2.amazonaws.com/jourdata/jcdr/JCardVascDisRes-9-2-59_g001.jpg

The severity of pain at rest in group B was statistically significant at 0 and 8hr (Graph 3A). The severity of pain was statistically significant at 0, 8, 12 and 24hr with deep breathing in group B as shown in (Graph 3B) and pain score at various time interval at rest and deep breathing is shown in (Graph 4).

Graph 3

Comparison of Pain at Rest (A) And Deep Breathing (B) At Various Time Interval between the Groups.

https://s3-us-west-2.amazonaws.com/jourdata/jcdr/JCardVascDisRes-9-2-59_g003.jpg
Graph 4

Comparison of Pain Score at Rest (R) and Deep Breathing (D) At Various Time Interval between the Groups.

https://s3-us-west-2.amazonaws.com/jourdata/jcdr/JCardVascDisRes-9-2-59_g004.jpg

The number of rescue analgesia given were significantly more between 0 to 24 hr in Group B (2 ± 0.926) as compared to Group A (0.27 ± 0.702). (Graph 5).

Graph 5

Break through episodes and rescue analgesia between Group A (PVB) vs Group B (Control).

https://s3-us-west-2.amazonaws.com/jourdata/jcdr/JCardVascDisRes-9-2-59_g005.jpg

Three patients in group B had postoperative vomiting but none in group A and this was statistically insignificant.

The length of ICU stay was lower in Group A (2.40 ± 0.51 days) as compared to Group B (3.13 ± 0.83 days) as shown in Graph 6, but, was statistically insignificant (p value 0.439). The length of hospital stay was comparable between the groups 8.27 ± 1.23 days and 9.27±1.90 days respectively (p value 0.560) as shown in Graph 6.

Graph 6

Length of ICU and Hospital stay between 2 groups.

https://s3-us-west-2.amazonaws.com/jourdata/jcdr/JCardVascDisRes-9-2-59_g002.jpg

DISCUSSION

Postoperative pain after cardiac surgery remains a challenge that may be associated with increased morbidity and mortality. Previous studies have shown that ineffective pain management may lead to serious pulmonary complications because of insufficient clearance of secretions, mucous plugging and atelectasis.7-9

Various treatment modalities have been introduced for the postoperative pain management in cardiac surgery. PVB is a well-accepted technique for post thoracotomy pain relief. It is a safer and easier technique to perform.10 PVB affects intercostal nerves, ipsilateral sympathetic chain and posterior rami.3 Continuous infusion of a local anaesthetic provides effective analgesia, maintains hemodynamic stability, restores respiratory mechanics and prevents pulmonary complications.11

Dhole et al has found PVB to be as effective as thoracic epidural analgesia (TEA) after minimally invasive direct coronary artery bypass grafting surgery (MIDCAB).1 Hypotension and urinary retention occurred less frequently in the PVB group, as compared to continuous TEA which may be an additional advantage of this technique over TEA.1 Yatin Mehta et al have compared PVB to TEA in robotic assisted coronary artery bypass surgery and found no difference in intraoperative hemodynamic parameters in both the groups.3 The potential risk of an epidural hematoma after puncture of epidural vessels and subsequent anticoagulation is a major concern with regard to the TEA technique which is not seen with PVB.

Canto and colleagues, in 2003, studied continuous bilateral PVB for conventional cardiac surgery. They found lower pain scores during the ICU stay, with good hemodynamic stability and a lower rate of pulmonary complication.12

The severity of pain (0 hr and 8 hr at rest and 0,8,12 and 24 hr with deep breathing) in Group A was lesser compared to Group B after extubation, which was statistically significant. The number of rescue analgesia was also less in PVB group. The results of the present study suggest that analgesic effects of paravertebral block were better than intravenously administered opioids. PVB also offers significant advantage in terms of post-operative pain relief, reduced opioid consumption, reduced incidence of postoperative nausea and vomiting (PONV), decreased ICU stay and better patient satisfaction.13-14

PVB in conjunction with general anaesthesia, Wetz et al.13 and Coveney et al.14 both demonstrated significant cost saving (up to 22%). The lower cost was attributed to reduced need for post operative monitoring and nursing staff.

In the present study the length of ICU stay was lower in Group A (2.4 ± 0.51) as compared to Group B (3.13 ± 0.83) but statistically insignificant.

Although rare, complications can occur with PVB. The most notable include pleural puncture and epidural spread of local anaesthetic agents. In our study no such complications were observed. Relative small sample size is one of the limitation of the study.

CONCLUSION

Bilateral PVB can be a feasible, safe and effective technique for perioperative analgesia in patients undergoing OPCAB surgery.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

SUMMARY

Bilateral parvertebral block is a feasible tedchnique for perioperative analgesia in patients undergoing OPCAB surgery. Bilateral PVB provides superior analgesia with hemodynamic stability and decreases the use of intravenous opioids allowing early extubation and shorter ICU stay.

ACKNOWLEDGEMENT

Thankful to all the patients who have consented for the study

ABBREVIATIONS

OPCAB

Off Pump Coronary Artery Bypass Surgery

MIDCAB

Minimally Invasive Direct Coronary Artery Bypass Surgery

PVB

PARAVERTEBRAL BLOCK

CSF

Cerbrospinal Fluid

VAS

Visual Analogue Scale

TEA

Thoracic Epidural Analgesia

PONV

Post-operative Nausea And Vomiting

REFERENCES

1. 

Dhole S, Mehta Y, Saxena H, Juneja R , authors. Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for Postoperative Analgesia after Minimally Invasive Direct Coronary Artery Bypass Surgery. J Cardiothorac Vasc Anesth. 2001;15(3):288–92

2. 

Ganapathy S, Murkin JM, Boyd DW, Dobkowski W, Morgan J , authors. Continuous percutaneous paravertebral block for minimally invasive cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 1999;13(5):594–6

3. 

Mehta Y, Dheeraj ; Sharma K, Mishra Y, et al. , authors. Comparison of continuous thoracic epidural and paravertebral block for post operative analgesia after robotic assisted coronary artery bypass surgery. Annals of Cardiac Anaesthesia. 2008;11(2):91–6

4. 

Richardson J, Vowden P, Sabanathan S , authors. Bilateral paravertebral analgesia for major abdominal vascular surgery: A preliminary report. Anaesthesia. 1995;50:995–8

5. 

Karmakar MK, Booker PD, Franks R , authors. Bilateral continuous block used for postoperative analgesia in an infant having bilateral thoracotomy. Paediatric Anaesthesia. 1997;7(6):469–71

6. 

Nair V, Henry R , authors. Bilateral paravertebral block: A satisfactory alternative for labour analgesia. Canadian Journal of Anaesthesia. 2001;48(2):179–84

7. 

Hardy I, Ahmed S , authors. Pain control following thoracic surgery. Ghosh S, Latimer R , authors. Thoracic anaesthesia- principles and practice Oxford: Butterworth - Heinemann; 1999. p. 265–7

8. 

Catala E, Casas JI, Unzueta MC, Diaz X, Alliaga L, Villar Landeira JM , authors. Continuous infusion is superior to bolus doses with thoracic paravertebral blocks after thoracotomies. J Cardiothorac Vasc Anesth. 1996;10(5):586–8

9. 

Canto M, Sanchez MJ, Casas MA, Bataller ML , authors. Bilateral paravertebral blockade for conventional cardiac surgery. Anaesthesia. 2003;58(4):365–70

10. 

Takamori S, Yoshida S, Hayashi A, Matsuo T, Mitsuoka M, Shirouzu K , authors. intraoperative intercostals nerve blockade for post-thoracotomy pain. Ann thorac surg. 2002;74(2):338–41

11. 

Kaiser AM, Zollinger A, De Lorenzi D, Largiader F, Weder W , authors. prospective, randomized comparison of extraplural versus epidural analgesia for post thoracotomy pain. Ann Thorac Surg. 1998;66(2):367–72

12. 

Ballantyne JC, Carr DB, De Ferranti S, Soarez T, Lau J, Chalmers TC, et al. , authors. the comparative effects of post-operative analgesic therapies on pulmonary outcome : cumulative meta-analysis of randomized, controlled trial. Anesth analg. 1998;86:598–612. Weltz CR, Greengrass RA, Lyely HK , authors. Ambulatory surgical management of breast carcinoma using paravertebral block. Ann surg. 1995;222:19–26

13. 

Coveney E, Weltz CR, Greengrass R , authors. Use of paravertebral block anaesthesia in the surgical management of breast cancer: Experience in 156 cases. Ann Surg. 1998;227(4):496–501